As a member of PDCI’s Strategic Consulting and Policy Team, Courtney helps clients make business decisions that will achieve optimal pricing and reimbursement for their products. She has lead dozens of market access assessments, providing insights to clients about the market access landscape and recommending strategies and roadmaps to optimize access in ever-evolving therapeutic and access landscapes. Courtney has assisted clients to prepare for public and private reimbursement negotiations, including assessing points of leverage between negotiating parties and recommending deal structures that anticipate and satisfy payer needs without compromising value. Additionally, Courtney has led dozens of payer research and advisory board projects, broadening her market access knowledge, insights and connections beyond PDCI’s in-house expertise, and becoming sensitive to nuances of various payer and other stakeholder perspectives from coast to coast.
In addition to her work assisting clients with business decisions directly, Courtney leads PDCI policy projects in a wide variety of topics of interest to the innovative pharmaceutical industry. In this work, she has conducted primary and secondary research to author reports delivering novel insights on topics such as national pharmacare and the private payer PLA landscape in Canada.
Prior to joining PDCI’s Strategic Consulting and Policy Team, Courtney managed and led pricing and reimbursement submission projects, contributing to the strategic planning and development for all HTA submission components in consultation with clients and internal PDCI teams. This experience, combined with her skill for clear communication, has assisted clients to develop and effectively communicate the narrative demonstrating product value to stakeholders.